» Articles » PMID: 36804863

SGLT2 Inhibitor Versus Carbohydrate-restricted Isocaloric Diet: Reprogramming Substrate Oxidation in Type 2 Diabetes

Overview
Publisher Biomed Central
Specialty Endocrinology
Date 2023 Feb 22
PMID 36804863
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Based on the whole-body energy metabolism and insulin action, the difference between increased excretion of carbohydrate in urine by SGLT2i and reduced same amount of oral carbohydrate intake are scarce. This study aimed to compare the effect of carbohydrate availability with reduced oral intake (carbohydrate-restricted isocaloric diet: CRIC diet) or lost in urine, as urinary glucosuria on sodium/glucose cotransporter-2 inhibitor (SGLT2i) treatment, focus on the insulin requirement and the macronutrient oxidation within insulin treated type 2 diabetes.

Methods: This is randomized 3-arm open-label prospective study. Subjects treated with titrated basal-bolus insulin regimen subsequent to three diet regimens, control diet (CON), administration of canagliflozin 100 mg/day to CON (SGLT2i), or CRIC diet, with a week admission to the endocrinology ward followed by 12 weeks outpatients' management. The main outcome measures including the total insulin dose (TID) required to achieve euglycemia, fasting and postprandial energy expenditure (EE) and respiratory quotient (RQ) at 1-week and 12-week.

Results: We enrolled 23 patients with type 2 diabetes (male/female: 14/9, age: 53.6 ± 14.2 years, body mass index: 26.9 ± 4.8 kg/m, HbA1c: 12.5 ± 1.6%). The TID was similar with CON and SGLT2i at both 1 and 12-weeks. Although comparable net carbohydrate availability in SGLT2i and CRIC groups, the TID was significantly higher in the CRIC (p = 0.02) compare to the SGLT2i at both 1 and 12-weeks. Fasting EE was similar in all groups, postprandial EE was significantly elevated in the SGLT2i and CRIC groups compared to the CON group (p = 0.03 and 0.04). Compare to the CON, lower basal fasting RQ (p = 0.049) and decreased delta-RQ (postprandial RQ/fasting RQ) indicated continuous lipid substrate utilization in the SGLT2i (p = 0.04) and CRIC (p = 0.03) groups.

Conclusion: The CRIC diet resulted in a similar fasting and postprandial EE and substrate oxidation compared to the SGLT2i. The increased insulin requirement in the CRIC diet indicates that a relatively highly lipid and protein consumption, compared to the SGLT2i and CON, may influence insulin requirement.

Citing Articles

Relationship between sodium-glucose cotransporter-2 inhibitors and muscle atrophy in patients with type 2 diabetes mellitus: a systematic review and meta-analysis.

Xia C, Han Y, Yin C, Geng R, Liu Z, Du Y Front Endocrinol (Lausanne). 2023; 14:1220516.

PMID: 37780608 PMC: 10541228. DOI: 10.3389/fendo.2023.1220516.

References
1.
. ICH harmonized tripartite guideline: Guideline for Good Clinical Practice. J Postgrad Med. 2001; 47(1):45-50. View

2.
Schonfeld P, Wojtczak L . Short- and medium-chain fatty acids in energy metabolism: the cellular perspective. J Lipid Res. 2016; 57(6):943-54. PMC: 4878196. DOI: 10.1194/jlr.R067629. View

3.
Rajeev S, Cuthbertson D, Wilding J . Energy balance and metabolic changes with sodium-glucose co-transporter 2 inhibition. Diabetes Obes Metab. 2015; 18(2):125-34. DOI: 10.1111/dom.12578. View

4.
Ferrannini E, Muscelli E, Frascerra S, Baldi S, Mari A, Heise T . Metabolic response to sodium-glucose cotransporter 2 inhibition in type 2 diabetic patients. J Clin Invest. 2014; 124(2):499-508. PMC: 3904627. DOI: 10.1172/JCI72227. View

5.
Martin G, Tapsell L, Denmeade S, Batterham M . Relative validity of a diet history interview in an intervention trial manipulating dietary fat in the management of Type II diabetes mellitus. Prev Med. 2003; 36(4):420-8. DOI: 10.1016/s0091-7435(02)00054-3. View